The MAST Program is excited to be at #ENDO2026 this weekend in Chicago, sharing research that continues to uncover the connections between the gut microbiome and metabolic disease. This @CedarsSinai article highlights the work of Gabriela Leite, PhD, and Ruchi Mathur, MD, whose research presented at ENDO 2026 explores a potential connection between the small bowel microbiome and PCOS. Their findings suggest that a bacterium found in the human small intestine may contribute to hormonal and reproductive changes associated with the condition. These findings add to the growing evidence that the small bowel microbiome may play an important role in endocrine and reproductive health. If you're attending ENDO 2026, be sure to stop by and explore the latest research from the MAST team. We look forward to connecting with colleagues, sharing discoveries, and advancing the science that brings us closer to better patient care. 🔗 Read the full article (cedars-sinai.org/newsroom/ce…) #ENDO2026 #MASTProgram #CedarsSinai #Microbiome #IBS #SIBO #IMO #PCOS #Obesity #GutMicrobi

🚨 We're heading to Chicago! This weekend, the MAST Program is bringing our latest research to ENDO 2026. Stop by our poster presentations to learn more about how we're exploring the connections between the gut microbiome, metabolism, and patient outcomes. Every study presented represents another step toward advancing our understanding of complex GI and metabolic conditions. If you're attending ENDO, come say hello, check out our posters, and join the discussion. We can't wait to share our work and learn from the incredible science being presented throughout the meeting. See you in Chicago! #ENDO2026 #GutMicrobiome #MetabolicHealth #DigestiveHealth #Research #MASTProgram

The MAST Program is currently looking for participants in a clinical trial for a new therapy. If you are a patient with Irritable Bowel Syndrome with Diarrhea (IBS-D), have had a colonoscopy in the last 3 years, and live in the greater LA area, please contact us. You can find the link to the study in the comments below. Please feel free to fill out the form or give us a call at (310) 423-3792 #MASTProgram #IBS #IBSD #ClinicalTrial

🌈 Happy Pride Month from the MAST Program! This month, we celebrate the LGBTQ community and reaffirm our commitment to fostering a healthcare and research environment where every individual feels seen, respected, and heard. At MAST, we believe that advancing science means advancing care for everyone. Inclusive research and equitable healthcare are essential to improving outcomes and ensuring that all patients have access to the understanding, support, and treatment they deserve. Throughout Pride Month and beyond, we stand with LGBTQ patients, researchers, healthcare providers, and advocates working to build a healthier and more inclusive future. Happy Pride! #PrideMonth #Pride2026 #LGBTQHealth #HealthEquity #InclusiveResearch #MASTProgram

📍 Next Stop: Chicago! The MAST Program is excited to be heading to ENDO 2026 next week to share our latest research and join leading scientists, clinicians, and innovators from around the world in advancing endocrine and metabolic health. If you'll be attending ENDO 2026, be sure to follow along as we share updates from our presentations and highlights from the meeting throughout the week. We look forward to seeing you in Chicago! #ENDO2026 #Endocrinology #MetabolicHealth #MicrobiomeResearch #GutHealth #Research #MASTProgram

As Digestive Health Month comes to a close, we’re recognizing World Digestive Health Day by continuing the conversation around the importance of gut health and the patients living with digestive disorders every day. At MAST, digestive health isn’t just something we focus on in May; it’s at the center of everything we do. Digestive diseases impact millions worldwide, yet many patients still face delayed diagnoses, stigma, or feeling dismissed in their healthcare journey. Awareness and research are critical to changing that. This World Digestive Health Day, we celebrate the progress being made in digestive health research while continuing to push forward toward a future with better understanding, better treatments, and better outcomes for patients. #WorldDigestiveHealthDay #DigestiveHealthMonth #GutHealth #Microbiome #GIResearch #IBS #SIBO #DigestiveHealth #MASTProgram

Today, on International Day of Action for Women’s Health, we recognize the importance of listening to women, believing women, and taking women’s symptoms seriously. For women living with IBS and other digestive disorders, pain is minimized, symptoms are dismissed, and answers are delayed. Medical gaslighting remains a real barrier to care, and it can have lasting impacts on both physical and mental health. At MAST, our research is driven by the belief that every patient deserves to be heard. Through advancing the science of the gut microbiome and GI health, we hope to help create a future where women receive the validation, care, and treatment they deserve. Because being told “it’s all in your head” is not healthcare. Listening is. #InternationalDayOfActionForWomensHealth #WomensHealth #IBS #GutHealth #DigestiveHealth #Microbiome #MASTProgram

The conversation around thyroid health and the gut microbiome is growing! Following Cedars-Sinai’s recent feature on Dr. Ruchi Mathur and MAST’s research, MedPage Today is now highlighting these findings and the emerging connection between hypothyroidism and small intestinal bacterial overgrowth (SIBO). Our research found that patients with hypothyroidism may have more than double the risk of developing SIBO, with even higher risk seen in autoimmune thyroid disease, adding to the growing understanding of how the microbiome may influence health far beyond the GI tract. At MAST, we are proud to continue advancing research that not only deepens our scientific understanding but also helps improve the lives of the patients affected by these conditions every day. We’re excited to see this work gaining broader attention and grateful to everyone involved in pushing this research forward. 🔗 Read the MedPage Today linked below #MASTProgram #CedarsSinai #Microbiome #Hypothyroidism #SIBO #ThyroidHealth #GutMicrobiome

New findings from Cedars-Sinai are highlighting an important connection between thyroid health and the gut microbiome. 🦠 Research led by Dr. Ruchi Mathur and the MAST team found that patients with hypothyroidism may be at greater risk for developing small intestinal bacterial overgrowth (SIBO), further emphasizing the complex relationship between endocrine and GI health. At MAST, we’re proud to support research that continues to uncover the ways the microbiome influences whole-body health, helping pave the way for more personalized care. Congratulations to Dr. Mathur and the entire research team on this exciting work! 🔗 Read the full Cedars-Sinai article linked below #MASTProgram #CedarsSinai #Microbiome #Hypothyroidism #SIBO #ThyroidHealth #GutMicrobiome